Cite
HARVARD Citation
Amini, N. et al. (2022). Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?. Journal of hepato-biliary-pancreatic sciences. pp. 417-427. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Amini, N. et al. (2022). Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?. Journal of hepato-biliary-pancreatic sciences. pp. 417-427. [Online].